JP2013536227A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013536227A5 JP2013536227A5 JP2013525975A JP2013525975A JP2013536227A5 JP 2013536227 A5 JP2013536227 A5 JP 2013536227A5 JP 2013525975 A JP2013525975 A JP 2013525975A JP 2013525975 A JP2013525975 A JP 2013525975A JP 2013536227 A5 JP2013536227 A5 JP 2013536227A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- cancer
- cycloalkyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 26
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 201000011510 cancer Diseases 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims 23
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 2
- 206010005003 Bladder cancer Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000032612 Glial tumor Diseases 0.000 claims 1
- 206010018338 Glioma Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- -1 and R d is H Chemical group 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 125000006255 cyclopropyl carbonyl group Chemical group [H]C1([H])C([H])([H])C1([H])C(*)=O 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 208000014018 liver neoplasm Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 201000005112 urinary bladder cancer Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37553410P | 2010-08-20 | 2010-08-20 | |
| US61/375,534 | 2010-08-20 | ||
| PCT/US2011/047899 WO2012024282A2 (en) | 2010-08-20 | 2011-08-16 | 1,5-diphenyl-penta-1,4-dien-3-one compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013536227A JP2013536227A (ja) | 2013-09-19 |
| JP2013536227A5 true JP2013536227A5 (enExample) | 2014-09-25 |
| JP5998139B2 JP5998139B2 (ja) | 2016-09-28 |
Family
ID=45594547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013525975A Expired - Fee Related JP5998139B2 (ja) | 2010-08-20 | 2011-08-16 | １，５−ジフェニル−ペンタ−１，４−ジエン−３−オン化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8822732B2 (enExample) |
| EP (3) | EP3045445B1 (enExample) |
| JP (1) | JP5998139B2 (enExample) |
| KR (1) | KR101907631B1 (enExample) |
| CN (3) | CN103459361A (enExample) |
| AR (2) | AR082856A1 (enExample) |
| AU (1) | AU2011292144B2 (enExample) |
| CA (1) | CA2807776C (enExample) |
| NZ (1) | NZ607653A (enExample) |
| SG (1) | SG188217A1 (enExample) |
| TW (1) | TWI574686B (enExample) |
| WO (1) | WO2012024282A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG188217A1 (en) * | 2010-08-20 | 2013-04-30 | Androscience Corp | 1,5-diphenyl-penta-1,4-dien-3-one compounds |
| WO2014022660A1 (en) * | 2012-08-03 | 2014-02-06 | Georgia State University Research Foundation, Inc. | Curcumin analogs and methods of making and using thereof |
| CN103910616A (zh) * | 2014-03-20 | 2014-07-09 | 浙江工业大学 | 一种姜黄素衍生物及其制备与应用 |
| CN104974038B (zh) * | 2014-04-13 | 2019-04-30 | 江苏康缘药业股份有限公司 | 一种含羧基单羰基姜黄素衍生物及其制备方法和应用 |
| CN103922911A (zh) * | 2014-04-17 | 2014-07-16 | 上海应用技术学院 | 一种(1e,4e)-1,5-二(邻溴间甲氧基苯基)-1,4-戊二烯酮化合物及合成方法 |
| WO2019152536A1 (en) | 2018-01-30 | 2019-08-08 | The Regents Of The University Of California | Inhibitors of the wnt/beta-catenin pathway |
| KR20200130389A (ko) * | 2018-03-08 | 2020-11-18 | 피아이 테라퓨틱스 리미티드 | 단백질 분해를 저해하기 위한 화합물 및 암의 치료에서의 이의 사용 방법 |
| CN108864188B (zh) * | 2018-09-06 | 2020-06-23 | 贵州大学 | 一种含亚磷酸酯的1,4-戊二烯-3-酮类衍生物、其制备方法及应用 |
| CN109942540B (zh) * | 2019-04-22 | 2021-06-18 | 贵州大学 | 一种含噻吩磺酸酯的1,4-戊二烯-3-酮类衍生物、其制备方法及应用 |
| CN109970704B (zh) * | 2019-04-22 | 2022-01-28 | 贵州大学 | 一种含噻吩磺酸酯的查耳酮类衍生物、其制备方法及应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2084208A1 (en) * | 1990-05-17 | 1991-11-18 | Barry Markaverich | Growth inhibitors and methods of treating cancer and cell proliferative diseases |
| JPH0829977A (ja) * | 1994-07-18 | 1996-02-02 | Nippon Zeon Co Ltd | ポジ型レジスト組成物 |
| JP3383724B2 (ja) * | 1995-05-11 | 2003-03-04 | ライオン株式会社 | 分散剤 |
| AU779230C (en) | 1999-12-03 | 2006-05-25 | Emory University | Curcumin analogues for treating cancer |
| US20050069551A1 (en) * | 2002-03-08 | 2005-03-31 | Emory University | Cytotoxic compound-protein conjugates as suppressors of tumor growth and angiogenesis |
| US20060276536A1 (en) | 2004-02-12 | 2006-12-07 | Vander Jagt David L | Cancer treatment using curcumin derivatives |
| US8178727B2 (en) * | 2005-06-27 | 2012-05-15 | National University Corporation Tohoku University | Bis(arylmethylidene)acetone compound, anti-cancer agent, carcinogenesis-preventive agent, inhibitor of expression of Ki-Ras, ErbB2, c-Myc and Cycline D1, β-catenin-degrading agent, and p53 expression enhancer |
| JP2008029977A (ja) * | 2006-07-31 | 2008-02-14 | Ntn Corp | エアロゾル吐出ノズルおよび被膜形成装置 |
| CN101711231B (zh) * | 2007-01-08 | 2014-03-12 | 安德鲁科技有限公司 | 具有(取代苯基)-丙烯醛部分的化合物、它们的衍生物、生物活性及其用途 |
| US8329757B2 (en) * | 2008-10-14 | 2012-12-11 | Charlesson, Llc | Curcumin analog compositions and related methods |
| CN101475455A (zh) * | 2009-02-10 | 2009-07-08 | 贵州大学 | 1,5-二取代芳基-1,4-戊二烯-3-酮衍生物及制备方法和用途 |
| SG188217A1 (en) * | 2010-08-20 | 2013-04-30 | Androscience Corp | 1,5-diphenyl-penta-1,4-dien-3-one compounds |
-
2011
- 2011-08-16 SG SG2013011127A patent/SG188217A1/en unknown
- 2011-08-16 US US13/210,728 patent/US8822732B2/en not_active Expired - Fee Related
- 2011-08-16 CA CA2807776A patent/CA2807776C/en not_active Expired - Fee Related
- 2011-08-16 KR KR1020137004265A patent/KR101907631B1/ko not_active Expired - Fee Related
- 2011-08-16 JP JP2013525975A patent/JP5998139B2/ja not_active Expired - Fee Related
- 2011-08-16 EP EP16152929.2A patent/EP3045445B1/en not_active Not-in-force
- 2011-08-16 AU AU2011292144A patent/AU2011292144B2/en not_active Ceased
- 2011-08-16 CN CN2011800404067A patent/CN103459361A/zh active Pending
- 2011-08-16 CN CN201710311576.3A patent/CN107266340A/zh active Pending
- 2011-08-16 WO PCT/US2011/047899 patent/WO2012024282A2/en not_active Ceased
- 2011-08-16 EP EP11818654.3A patent/EP2606021B1/en not_active Not-in-force
- 2011-08-16 EP EP19177745.7A patent/EP3564204A1/en not_active Withdrawn
- 2011-08-16 CN CN201710311577.8A patent/CN107253915A/zh active Pending
- 2011-08-16 NZ NZ607653A patent/NZ607653A/en not_active IP Right Cessation
- 2011-08-18 AR ARP110103015A patent/AR082856A1/es not_active Application Discontinuation
- 2011-08-19 TW TW100129846A patent/TWI574686B/zh not_active IP Right Cessation
-
2014
- 2014-08-28 US US14/471,539 patent/US9359279B2/en not_active Expired - Fee Related
-
2018
- 2018-09-04 AR ARP180102505A patent/AR112787A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013536227A5 (enExample) | ||
| JP2010540556A5 (enExample) | ||
| JP2019518766A5 (enExample) | ||
| JP2014193925A5 (enExample) | ||
| JP2010539095A5 (enExample) | ||
| JP2013502423A5 (enExample) | ||
| JP2019535746A5 (enExample) | ||
| AR066904A1 (es) | Pirrolopiridinas y pirazolopiridinas sustituidas como moduladores de las quinasas, una composicion farmaceutica que las incluye y su uso en el tratamiento del cancer | |
| JP2009526034A5 (enExample) | ||
| JP2016503799A5 (enExample) | ||
| CN112469718A (zh) | 氮杂吲哚衍生物及其作为FGFR和C-Met抑制剂的应用 | |
| JP2019524883A5 (enExample) | ||
| JP2017511321A5 (enExample) | ||
| JP2010241830A5 (enExample) | ||
| JP2015537008A5 (enExample) | ||
| JP2013510120A5 (enExample) | ||
| JP2014513704A5 (enExample) | ||
| JP2016518328A5 (enExample) | ||
| JP2014528467A5 (enExample) | ||
| EA201391324A1 (ru) | Бис(фторалкил)-1,4-бензодиазепиноновые соединения | |
| JP2018529650A5 (enExample) | ||
| RU2014115847A (ru) | Пирролопиримидиновые соединения для лечения злокачественной опухоли | |
| JP2016525130A5 (enExample) | ||
| JP2014526533A5 (enExample) | ||
| JP2013518089A5 (enExample) |